GLP-1 / Metabolic

Adipotide

Also known as: FTPP

Adipotide (FTPP) is a chimeric peptidomimetic developed in the Arap/Pasqualini lab (originally at MD Anderson) that couples a 9-residue homing motif (CKGGRAKDC) — isolated by in vivo phage display as a ligand for prohibitin on white-adipose-tissue vasculature — to the D-amino-acid pro-apoptotic domain D(KLAKLAK)2. It is an experimental research compound, NOT FDA-approved for any indication. A clinical-development program in prostate-cancer-associated obesity reached early-phase testing and was ultimately discontinued.

Vendors carrying Adipotide

0 listings, ranked by trust score

Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.

No vendors carrying this peptide are indexed yet.

Independent evidence

No COAs on file for Adipotide

No third-party tests indexed yet. Phase 2 will surface more vendor evidence as the dataset grows.